Last Updated on October 10, 2024 by The Health Master
Strides Pharma Science Ltd has said its Singapore-based firm Strides Pharma Global Pvt Ltd has received approval from the US Food and Drug Administration (USFDA) for a generic version of oseltamivir phosphate for oral suspension, used for treating diseases caused by influenza.
The product is bioequivalent and therapeutically equivalent to the reference listed drug, Tamiflu for oral suspension, 6 mg/ml, of Hoffmann-La Roche, Inc, the company said in a statement on January 17, 2022.
The product will be manufactured at the company’s facility in Bengaluru and will be marketed by Strides Pharma Inc in the US market.
USFDA approves drug for the treatment of Eczema
USFDA gives nod to Glenmark for Nasal Spray to treat allergic rhinitis
USFDA gives tentative nod to Alembic for Dronedarone tablets
USFDA gives nod to Alembic Pharma for Vortioxetine tablets
USFDA gives nod to Alembic for generic drug to treat Parkinson’s disease
USFDA gives nod to Alembic Pharma for Doxycycline Hyclate tablets
Pharmaceutical Budget 2022: Expectations
NPPA to conduct study on Price Regulatory Policies in these 10 countries
IPC flags safety alert against Covid-19 drug Remdesivir
FDA alerts Medical Officers to maintain healthy Oxygen status
Which medicine works best for Covid-19 treatment? WHO answers
Govt notifies New Drugs and Clinical Trials (Amendment) Rules 2022
Drug recall: Sun Pharma, Lupin recall these drugs
BIS notifies new standard for these Medical Devices
Latest Notifications: Medical Devices
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
